1. Home
  2. SKYT vs TYRA Comparison

SKYT vs TYRA Comparison

Compare SKYT & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$32.31

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$30.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYT
TYRA
Founded
1991
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SKYT
TYRA
Price
$32.31
$30.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$19.40
$34.80
AVG Volume (30 Days)
2.5M
581.6K
Earning Date
02-25-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.62
N/A
Revenue
$346,587,000.00
N/A
Revenue This Year
$28.48
N/A
Revenue Next Year
$41.29
N/A
P/E Ratio
$11.97
N/A
Revenue Growth
0.19
N/A
52 Week Low
$5.67
$6.42
52 Week High
$36.27
$31.56

Technical Indicators

Market Signals
Indicator
SKYT
TYRA
Relative Strength Index (RSI) 67.96 66.88
Support Level $29.80 $27.40
Resistance Level $36.07 $31.56
Average True Range (ATR) 3.24 2.01
MACD 0.15 -0.11
Stochastic Oscillator 68.57 71.65

Price Performance

Historical Comparison
SKYT
TYRA

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: